FAR2P4

Across TCGA pan-cancer cohorts, FAR2P4 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated FAR2P4 data layer.

The strongest signal is observed in lymphoid neoplasm diffuse large b-cell lymphoma (DLBC), where higher FAR2P4 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated FAR2P4 expression acts as an unfavorable survival marker, although some lineages such as PAAD and ESCA show a favorable association.

DLBC, OV, and LUSC are the cancer types where FAR2P4 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
DLBC	DFS	Tertile	II,III,IV	0.124	0.884	<.001	57	view →
OV	OS	Median	All	0.628	0.745	<.001	54	view →
LUSC	DFS	Median	II,III,IV	0.505	0.674	.003	52	view →
LIHC	DFS	Median	All	0.438	0.611	<.001	40	view →
COAD	DFS	Quartile	II,III,IV	0.218	0.528	.003	39	view →
PRAD	DFS	Tertile	All	0.841	0.941	.002	22	view →
LUAD	DFS	Tertile	All	0.509	0.712	<.001	20	view →
ACC	DFS	Tertile	II,III,IV	0.173	0.494	.015	18	view →
KIRC	DFS	Quartile	III,IV	0.324	0.517	.008	17	view →
PAAD	DFS	Median	All	0.568	0.267	.004	16	view →
ESCA	DFS	Tertile	All	0.900	0.479	.027	12	view →
KIRP	DFS	Quartile	IV	0.088	0.483	.008	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

FAR2P4–DLBC (DFS)

Open the DLBC breakdown →